Option chain shows key data for Clearmind Medicine's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Clearmind Medicine.

Clearmind Medicine (NASDAQ:CMND) Stock, Option Chain

Clearmind Medicine

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

SPRC

Cannabis

News

Health Care

Movers

Trading Ideas

General

CMND

SciSparc teams up with Clearmind Medicine on innovative therapies for binge behaviors and secures FDA approval for a Tourette Syndrome Phase 2b trial.

Why Is Psychedelic-SciSparc Stock Trading Higher On Monday?

Genetic,Research,And,Biotech,Science,Concept.,Human,Biology,And,Pharmaceutical

Equities

Markets

PSIL

Clearmind Medicine&#39;s stock rose 63.9% after receiving IRB approval for its Phase I/IIa trial of CMND-100, a drug for alcohol use disorder.

Why Is Penny Stock Clearmind Gaining Today?

movers image

Pre-Market Outlook

AEHR

AKAN

AMLI

CETX

CTCX

GLXG

GRTS

JTAI

KDLY

LILM

LKCO

LUXH

MLGO

MNTS

NIVF

TSLA

ZENA

Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Clearmind Medicine Inc

President Donald Trump issued an executive order on Wednesday requiring all federal agencies to have a representative from Elon Musk&#8217;s Department of Government Efficiency, marking a significant expansion of the billionaire&#8217;s influence over government operations.
What Happened:&nbsp;The executive order mandates that each federal agency appoint a DOGE representative to oversee spending and ensure transparency,&nbsp;<a href="https://www.politico.com/news/2025/02/26/trump-order-federal-agencies-doge-representative-00206359">Politico reports</a>. These representatives will work alongside agency leadership to monitor all expenditures, requiring managers to provide written justifications for payments and implement new systems for tracking expenses.
The order also freezes most government credit cards for 30 days and requires monthly spending reports to be submitted to DOGE administrator&nbsp;Amy Gleason. This information will be made public, except for certain law enforcement and intelligence activities.
&#8220;To ensure Government spending is transparent and Government employees are accountable to the American public,&#8221; the order states, outlining the responsibilities of DOGE representatives.
This move is part of a broader efficiency project led by Trump and Musk, which has already resulted in the termination of numerous federal contracts and the dismissal of thousands of public-sector workers.
See Also: <a href="https://www.benzinga.com/news/25/02/43994686/will-investors-push-back-against-trumps-massive-borrowing-plans">Will Investors Push Back Against Trump&#8217;s Massive Borrowing Plans?</a>
Why It Matters:&nbsp;The expansion of DOGE&#8217;s influence comes at a time when the effectiveness of Trump and Musk&#8217;s cost-cutting measures is being questioned. Despite claims of billions in savings,&nbsp;<a href="https://www.benzinga.com/markets/25/02/43972234/trump-and-elon-musks-cost-cutting-measures-fail-to-curb-rising-us-government-spending-report">government spending continues to rise</a>, primarily due to increasing expenditures on health and retirement programs, as well as growing interest payments.
The initiative has faced significant challenges, including the&nbsp;<a href="https://in.benzinga.com/25/02/43962278/elon-musks-doge-staffers-resign-refuse-to-dismantle-critical-public-services-white-house-hits-back-saying-trump-wont-be-stopped-by-protests-and-lawsuits">resignation of over 20 civil service employees</a>&nbsp;from DOGE, who cited concerns about dismantling critical public services. This setback, coupled with ongoing court challenges, has raised questions about the long-term viability of the administration&#8217;s approach to government reform.
Public opinion also appears to be mixed on Musk&#8217;s role in government. A recent Emerson College poll found that only 41% of voters approve of Musk&#8217;s performance at DOGE, with 45% disapproving. The poll also revealed limited support for some of DOGE&#8217;s more controversial proposals, such as eliminating the US Agency for International Development and the Department of Education.
White House Press Secretary Karoline Leavitt defended the administration&#8217;s approach, stating, &#8220;Anyone who thinks protests, lawsuits, and lawfare will deter President Trump must have been sleeping under a rock for the past several years.&#8221;
Photo Courtesy: Shutterstock.com
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
<li></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Politics

Elon Musk's Influence Over The Government Set To Increase, Trump Orders All Federal Agencies To Appoint A DOGE Commissar

SJW Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SJW#NASDAQ">SJW</a>) is looking for FY2025 Adj EPS of $2.90-$3.00 vs $2.95 analyst estimate..

Guidance

SJW Gr Sees FY2025 Adj EPS $2.90-$3.00 vs $2.95 Est

SJW Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJW#NYSE">SJW</a>) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0.55 by 34.55 percent. This is a 25.42 percent increase over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $197.82 million which beat the analyst consensus estimate of $187.48 million by 5.52 percent. This is a 15.46 percent increase over sales of $171.34 million the same period last year.

Earnings

Earnings Beats

SJW Gr Q4 Adj $0.74 Beats $0.55 Estimate, Sales $197.82M Beat $187.48M Estimate

Market observers warn an expanding U.S. budget deficit and aggressive trade policies under President Donald Trump could test investors&#8217; appetite for government debt, despite campaign promises <a href="https://www.benzinga.com/25/02/43587245/tariffs-are-the-only-way-to-fund-tax-cuts-without-deficit-expansion-argues-expert-as-it-takes-center-stage-in-donald-trumps-economic-plan">to lower borrowing costs</a>.
Treasury yields have fluctuated since Trump&#8217;s election, initially spiking to 4.8% before settling at 4.6%, according <a href="https://www.ft.com/content/0259de87-9488-404d-b418-cdb26a2a8f89">to the Financial Times</a>. Investors now balance inflation concerns against fears that new tariffs could slow economic growth.
The <a href="https://www.cbo.gov/system/files/2025-01/60870-Outlook-2025.pdf">Congressional Budget Office projects</a> the government deficit will reach $1.9 trillion, or 6.2% of GDP, by Sept. 30. It could grow to $2.7 trillion by 2035, far exceeding the 50-year average deficit of 3.8%.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>Many don&#8217;t know there are tax benefits when buying a unit as an investment —<a href="https://www.benzinga.com/money/casa-shares"> Here&#8217;s how to invest in real estate by mirroring BlackRock's big move</a></li>
</ul>
&#8220;The investment community in general is certainly uncertain, and perhaps nervous, but it&#8217;s not obvious whether they should be more worried about recession or inflation,&#8221; David Kelly, chief global strategist at JPMorgan Asset Management, told the Financial Times.
House Republicans <a href="https://apnews.com/article/house-republicans-budget-blueprint-trump-tax-cuts-ff2bddf31f4e7cb0928139072392a091">have proposed tax cuts potentially reaching $4.5 trillion</a>, alongside a $4 trillion debt ceiling increase. The <a href="https://www.crfb.org/press-releases/house-budget-allows-too-much-debt">Committee for a Responsible Federal Budget estimates</a> the changes could add $2.8 trillion to the deficit through 2034.
International investors have already shown signs of hesitation. Japan and China, the largest foreign Treasury holders, <a href="https://ticdata.treasury.gov/resource-center/data-chart-center/tic/Documents/slt_table5.html">reduced their positions throughout 2024.</a> Foreign investors sold $50 billion in long-term Treasuries in December alone, the highest amount since May 2021, according to the Financial Times.
&#8220;Is the debt financeable? It is, until it isn&#8217;t,&#8221; Mark Sobel, former Treasury official and U.S. chair of think-tank Official Monetary and Financial Institutions Forum, said.
Trending: If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?
Treasury Secretary Scott Bessent faces pressure to <a href="https://www.benzinga.com/government/regulations/25/02/43529306/tariffs-are-a-means-to-an-end-bessent-defends-trade-strategy-pushes-growth-plan">maintain market confidence while pursuing expansionary policies</a>. However, analysts suggest U.S. debt retains advantages through market liquidity and the dollar&#8217;s reserve currency status.
The Federal Reserve&#8217;s quantitative tightening program, reducing its Treasury holdings since mid-2022, adds another variable as the government potentially increases debt issuance, the Financial Times reported.
&#8220;The scale and scope of the fiscal deficit could be quite large and could be relatively long term,&#8221; Ed Al-Hussainy, rates analyst at Columbia Threadneedle Investments, told the Financial Times. &#8220;That&#8217;s the main thing that could be damaging for the rates market.&#8221;
Read Next:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/money/arrived-private-credit-fund">Bezos' Favorite Real Estate Platform Launches A Way To Ride The Ongoing Private Credit Boom</a></li>
</ul>

Will Investors Push Back Against Trump's Massive Borrowing Plans?

Citigroup analyst Steven Enders maintains Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) with a Buy and lowers the price target from $760 to $726.

Price Target

Analyst Ratings

INTU

Citigroup Maintains Buy on Intuit, Lowers Price Target to $726

Maxim Group analyst Tom Forte maintains Beyond (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) with a Buy and lowers the price target from $26 to $16.

BYON

Maxim Group Maintains Buy on Beyond, Lowers Price Target to $16

Ladenburg Thalmann analyst Paul Fremont upgrades Spire (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SR#NYSE">SR</a>) from Sell to Buy and announces $83 price target.

Upgrades

Ladenburg Thalmann Upgrades Spire to Buy, Announces $83 Price Target

Lake Street analyst Eric Martinuzzi maintains Backblaze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLZE#NASDAQ">BLZE</a>) with a Buy and lowers the price target from $12 to $11.

BLZE

Lake Street Maintains Buy on Backblaze, Lowers Price Target to $11

US Physical Therapy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>) reported quarterly earnings of $0.51 per share which missed the analyst consensus estimate of $0.69 by 26.09 percent. This is a 13.56 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $180.45 million which beat the analyst consensus estimate of $174.77 million by 3.25 percent. This is a 16.57 percent increase over sales of $154.80 million the same period last year.

Earnings Misses

USPH

US Physical Therapy Q4 Adj $0.51 Misses $0.69 Estimate, Sales $180.45M Beat $174.77M Estimate

Lake Street analyst Ben Klieve initiates coverage on Blade Air Mobility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDE#NASDAQ">BLDE</a>) with a Buy rating and announces Price Target of $6.5.

Initiation

BLDE

Lake Street Initiates Coverage On Blade Air Mobility with Buy Rating, Announces Price Target of $6.5

Barclays analyst Trevor Young downgrades ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) from Overweight to Equal-Weight and lowers the price target from $10 to $6.

Downgrades

Barclays Downgrades ZipRecruiter to Equal-Weight, Lowers Price Target to $6

If you've recently grabbed a coffee at a kiosk without speaking to anyone or scanned your groceries without a cashier, you're already experiencing the quiet revolution of automation. It might seem minor now, but <a href="https://www.benzinga.com/startups/25/01/43101102/elon-musk-the-richest-man-in-the-world-is-estimated-to-earn-over-23-million-every-single-hour-of-the-day-heres-how-hes-spending-it">according to Elon Musk</a>—founder of SpaceX, CEO of Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), and owner of X —these small shifts are just the start.
Back in 2017 at the World Government Summit, Musk famously said about universal basic income, "I don't think we're going to have a choice." It wasn't a political stance or even his personal preference—it was Musk realistically predicting the future. With artificial intelligence becoming increasingly advanced, he sees a world where jobs traditionally done by humans rapidly vanish.
Don't Miss:
<ul>
<li>The average 401(k) balance soars to a record-breaking high – <a href="https://www.benzinga.com/money/average-401k-balances-soars-to-record-high">Here's how to know if your nest egg is keeping pace.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>
But fast-forward a few years, Musk's vision has evolved. During an appearance at the 2024 VivaTech conference in Paris, he didn't just double down on universal income—he took it further. Musk now anticipates a scenario where society doesn't settle for basic income, but instead adopts something far more ambitious: a "high universal income."
"In a benign scenario <a href="https://www.benzinga.com/general/24/05/39044740/probably-none-of-us-will-have-a-job-elon-musk-predicts-massive-job-losses-due-to-ai">probably none of us will have a job</a>," Musk explained, emphasizing optimism despite the disruption. "But in that benign scenario, there will be universal high income—not universal base income—and there will be no shortage of goods or services."
That shift—from "basic" to "high" universal income—is critical. Musk believes that AI and automation will drive down the cost of goods and dramatically boost productivity, creating abundance. In other words, everyone will theoretically have access to whatever they need, and poverty as we know it could dramatically diminish.
But here's the catch: Musk sees another serious problem emerging, and it's not economic—it's psychological.
Trending: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
<h2 class="wp-block-heading">Will Automation Leave Us Feeling "Useless"?</h2>
As appealing as abundant income might sound, Musk is concerned about the meaning we draw from our work. In a future where robots and AI systems outperform us at almost everything, he worries about human dignity, identity, and fulfillment.
"The harder challenge is how do people then have meaning," Musk said. "If you're not needed, if there's not a need for your labor, how do you find meaning? Do you feel useless?"
It's a troubling question. Employment, for most people, isn't just about money—it's about self-worth, social connections, and personal growth. Losing this could create a crisis of meaning, even in a world of abundance.
<h2 class="wp-block-heading">AI and the Future of Work</h2>
Despite these deep concerns, Musk is largely optimistic about AI's impact. "I think the benign scenario is probably the most likely—probably 80% likely if you ask my opinion," he said. "Everyone will have access to as much in the way of goods and services as they would like."
His <a href="https://www.benzinga.com/startups/25/01/43335267/some-employees-survive-but-a-whole-lot-dont-says-elon-musks-biographer-about-his-demon-mode-in-which-hes-coldly-brutal-to-people">vision of the future workplace</a> is similarly bold. Work won't vanish altogether, but it'll be optional. Musk describes a world where working becomes more of a hobby or passion project than a necessity. "Long term … any job that somebody does will be optional. If you want to do a job as kinda like a hobby, you can do a job, but otherwise, the AI and robots will provide any goods and services you want."
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
<h2 class="wp-block-heading">Could Your Career Soon Become Optional?</h2>
Whether you're on board with Musk's predictions or skeptical, it's clear AI is already causing real disruption in the workplace. According to a <a href="https://www.brookings.edu/articles/generative-ai-the-american-worker-and-the-future-of-work/">Brookings Institution report</a> last fall more than 30% of all workers could soon find at least half of their current job tasks taken over by generative AI.
And it's not just about job security. Workers are feeling the strain in other ways, too. A <a href="https://www.grantthornton.com/insights/press-releases/2024/november/employee-burnout-continues-to-surge-as-mental-and-emotional-stress-mount">Grant Thornton study</a> last year found that 32% of employees reported their mental well-being worsened in the past year, while 30% saw improvement, and 38% remained about the same.
Musk's statements underline something profound: the conversation about AI and automation isn't simply about economics. It's about human purpose, identity, and what we value beyond money.
As we move into this uncertain, automated future, Musk's message is clear: universal income—perhaps a high universal income—might soon become inevitable. But the real challenge might not be figuring out how to pay for it. Instead, we may have to find entirely new ways of defining our worth in a world where machines do almost everything for us.
Read Next:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
</ul>

Personal Finance

'I Don't Think We're Going to Have a Choice': Elon Musk Predicts Universal Income Will Eventually Be 'High'—But Fears People Will Feel 'Useless'

Dynamic Aerostructures, which makes high-tech parts for U.S. fighter jets and SpaceX rockets, has <a href="https://www.benzinga.com/topic/bankruptcy">filed for bankruptcy</a>.
What Happened: According to <a href="https://www.bloomberg.com/news/articles/2025-02-26/aero-parts-maker-for-stealth-bomber-spacex-files-for-bankruptcy?sref=TBDibEcD">Bloomberg</a>, the Valencia, California-based company plans to auction itself off in a court-supervised sale.
Dynamic is owned by a private equity firm, Endeavour Capital. Dynamic&#8217;s operating unit, Forrest Machining, LLC (aka FMI Aerostructures) was <a href="https://endeavour.com/portfolio/dynamic-aerostructures-llc/">purchased</a> by Endeavour Capital in 2021. 
The company blamed quality-control issues, contracts and inflation-driven inventory costs for the financial nosedive. 
CEO Eric Ellis insists it's still "business as usual" while they search for a buyer, with an April 7 bid deadline set for potential suitors.
See Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43098271/canoo-files-bankruptcy-stock-falls-nasa-walmart-dod-usps">EV Startup Canoo Files For Bankruptcy After NASA, USPS, Walmart Partnerships Bear Little Fruit</a>
Why It Matters: The company is saddled with $55 million in debt. In addition to SpaceX, the company is also a key supplier for Blue Origin, Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), Lockheed Martin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), and Northrop Grumman Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>), including making parts for the B-2 Spirit stealth bomber.
The company&#8217;s situation also illustrates the challenging record of private equity and venture capital-backed companies. In 2024, PE-backed companies made up nearly 16% of the 694 total U.S. bankruptcy filings, per <a href="https://www.transacted.io/private-equity-portfolio-bankruptcies-hit-record-high-in-2024">Transact.io</a>, citing S&amp;P Capital data.
That's the highest annual tally since 2010.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/asset-sales/25/02/43811409/nikola-files-for-bankruptcy-seeks-auction-for-sale-of-its-assets">Nikola Files For Bankruptcy, Seeks Auction For Sale Of Its Assets</a></li>
</ul>
Photo: Shutterstock

Asset Sales

Tech

SpaceX Parts Supplier Dynamic Aerostructures Files For Bankruptcy, Bid Deadline Set

CIBC analyst Krista Friesen maintains Stantec (TSX:<a class="ticker" href="https://www.benzinga.com/stock/STN#TSX">STN</a>) with a Outperformer and raises the price target from C$134 to C$139.

TSX:STN

CIBC Maintains Outperformer on Stantec, Raises Price Target to C$139

CIBC analyst Paul Holden maintains Bank of Montreal (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BMO#TSX">BMO</a>) with a Outperformer and raises the price target from C$154 to C$156.

TSX:BMO

CIBC Maintains Outperformer on Bank of Montreal, Raises Price Target to C$156

AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) has outperformed the market over the past 10 years by 1.65% on an annualized basis producing an average annual return of 12.56%. Currently, AECOM has a market capitalization of $13.06 billion. 
Buying $1000 In ACM: If an investor had bought $1000 of ACM stock 10 years ago, it would be worth $3,254.71 today based on a price of $98.39 for ACM at the time of writing.
<h3>AECOM's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740611952_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMSI#NASDAQ">MMSI</a>) with a Outperform and lowers the price target from $115 to $111.

MMSI

Barrington Research Maintains Outperform on Merit Medical Systems, Lowers Price Target to $111

Telsey Advisory Group analyst Cristina Fernandez maintains Arhaus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARHS#NASDAQ">ARHS</a>) with a Outperform and maintains $11 price target.

ARHS

Telsey Advisory Group Maintains Outperform on Arhaus, Maintains $11 Price Target

Chardan Capital analyst Daniil Gataulin maintains Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) with a Buy and maintains $11 price target.

CGTX

Chardan Capital Maintains Buy on Cognition Therapeutics, Maintains $11 Price Target

Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) has outperformed the market over the past 10 years by 5.73% on an annualized basis producing an average annual return of 16.64%. Currently, Domino's Pizza has a market capitalization of $16.43 billion. 
Buying $1000 In DPZ: If an investor had bought $1000 of DPZ stock 10 years ago, it would be worth $4,587.42 today based on a price of $479.11 for DPZ at the time of writing.
<h3>Domino's Pizza's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740611037_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Domino's Pizza 10 Years Ago Would Be Worth This Much Today

Press Releases

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site

Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format

Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Legal

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Comments

Clearmind Medicine

Clearmind Medicine (CMND) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga